Discussion on Production Linked Incentive Scheme 2.0 (PLI 2.0) for Pharma and Medical Devices

The team at Ivy Law participated in a discussion organised by Invest India on PLI 2.0 for Pharma and Medical Devices. The discussion emphasised on the initiatives taken by the government through PLI 2.0, to encourage the pharmaceutical industry to enhance its manufacturing capabilities, to diversify the product mix to complex generics, to increase patented drugs, boost the value chain, and create additional opportunities for foreign investment. Expenditures by companies considered for eligible investments under PLI 2.0 were also deliberated. Vibrant views were exchanged amongst representatives from the pharmaceutical industry and the concerned government officials.